Medindia

X

/C O R R E C T I O N -- Peregrine Pharmaceuticals, Inc./

Saturday, September 8, 2007 General News J E 4
Advertisement
In the news release, Peregrine (Nasdaq: PPHM) Reports Data ShowingBavituximab's Potential to Shrink Prostate Tumors, issued earlier today byPeregrine Pharmaceuticals, Inc. over PR Newswire, the headline should read"Peregrine Researchers Report Data Showing Bavituximab's Potential to ShrinkHuman Prostate Tumors in Model of Relapsed Disease" rather than "PeregrineReports Data Showing Bavituximab's Potential to Shrink Prostate Tumors" asincorrectly transmitted by PR Newswire.

SOURCE Peregrine Pharmaceuticals, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Good Clinical Practice Journal Awards: Winners Ann...
S
Tarpinian: Misclassification is Theft